Stocks · News reference

This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

2026-08-06 12:15:21 UTCAvi Kapoor

Wall Street analysts change outlook on top names. See all rating changes, upgrades, downgrades and initiations at Benzinga's analyst ratings page.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Fiscal.ai2026-11-06 12:32:29 UTC
Coupang Granted Suspension for W201b Penalty Related to User Information Collection
Coupang has been granted a suspension of a 201 billion won penalty previously imposed regarding its collection of user information.
CPNG
Benzinga2026-11-06 00:24:27 UTCBenzinga Newsdesk
UBS Maintains Buy on Charles River, Raises Price Target to $387
CRL
Benzinga2026-11-05 18:48:37 UTCBenzinga Newsdesk
RBC Capital Maintains Outperform on Charles River, Raises Price Target to $352
CRL
Fiscal.ai2026-11-05 19:03:26 UTC
Financial Institutions Adjust Price Targets for Charles River Laboratories Following Q3 Earnings
Multiple investment firms, including UBS, Jefferies, RBC, and Deutsche Bank, updated their price targets for Charles River Laboratories International, Inc. on November 5, 2026, following the company's third-quarter earnings report.
CRL
Fiscal.ai2026-11-05 19:02:48 UTC
Bernstein Maintains Underperform Rating on Coupang, Lowers Price Target
Bernstein reaffirmed its 'Underperform' rating on Coupang and reduced its price target from $12 to $11.
CPNG
Benzinga2026-11-05 17:14:03 UTCBenzinga Newsdesk
Bernstein Maintains Underperform on Coupang, Lowers Price Target to $11
CPNG